Dr. Sattar, with nearly five decades of research experience, specializes in microbial pathogens, their environmental influence, and safe technologies for combating infectious agents. His research delves into how pathogens survive and spread via water, food, air, waste, and surfaces. Funding for his work comes from peer-reviewed sources and research contracts. He offers expertise to national and international agencies and the private sector. With an extensive publication record and over 350 invited lectures worldwide, Dr. Sattar's contributions to the field are substantial. Notable works include the 2013 reference text "Principles and Practice of Disinfection, Preservation & Sterilization" (5th ed; Wiley-Interscience). He's received several professional honors, including the M.S. Favero Lectureship, Lifetime Achievement Award, and the Hygieia Gold Medal.

Dr. Cote boasts over 35 years of expertise in public health risk assessment and environmental management. She advises governments and industries on chemical exposure risks and risk assessment implementation. An adjunct professor at the University of Colorado, she educates on environmental health, risk assessment, and public policy. Dr. Cote also teaches risk assessment at Rutgers University. Her research focuses on cancer, respiratory diseases, and enhancing risk assessment methods. She spent 27 years at the US Environmental Protection Agency, serving in roles like Senior Science Advisor, Division Director, and Associate Laboratory Director. Dr. Cote's influence extends globally, advising organizations like the World Health Organization and the National Institutes of Health.

Since 2002, Mr. McNair has led key aspects of Cerner's Big Data operations, ensuring data quality for over 700 healthcare institutions. His role focuses on using this data for predictive models and decision-support solutions. McNair's career at Cerner began in 1986, where he co-invented Discern Expert®, a real-time decision-support engine used globally. He held positions in regulatory affairs, served as a General Manager, and worked in pharmaceutical roles. McNair is a prominent figure in mathematical modeling, AI, and health finance, with over 100 patents and numerous publications. He's also active in volunteer work and academic pursuits.

Monique Macdonald brings 35 years of experience in office management and financial administration to her role as Office Administrator at RSI. Specializing in stakeholder liaison, data management, and bookkeeping, she also supports sales, marketing, and workshop administration. Monique holds a diploma in Business Administration and Accounting and has a background in both aerial surveying and industry association firms. Additionally, she serves as RSI’s Alternate Security Officer for federal government contracting services.

Don Mattison's career is an amalgamation of medicine, science, and public service. He started with a Bachelor's degree in Chemistry and Mathematics, followed by a Master's from MIT in Chemistry. He then pivoted to medicine, obtaining an MD from Columbia University and focusing on pharmacology and toxicology in reproductive health during his residencies. Mattison has held several prestigious appointments, including Dean of the University of Pittsburgh's Graduate School of Public Health and Chief Medical Officer at Risk Sciences International. Throughout his career, he obtained medical licenses in six U.S. states and served in the U.S. Public Health Service, retiring with the rank of Captain. Most recently, he became a Distinguished Professor of Epidemiology at the University of South Carolina.

Margaret Wilson holds a BSc, BEd, and MSc in Molecular Biology, with post-graduate certificates in Population Health Risk Assessment and Management. She has worked extensively in health risk research, from BSE risk management to foodborne hazards. Currently at RSI, her focus includes risk prioritization and addressing challenges related to climate change. Margaret's multidisciplinary background equips her to tackle complex risk issues effectively.

Dr. Peter Aggett, a Pediatrician specializing in Gastroenterology, Metabolism, and Chemical Pathology, focuses on essential trace elements in health and disease. He holds the position of Emeritus Head at Lancashire School of Health and Postgraduate Medicine and is a Professor of Child Health and Nutrition at the University of Central Lancashire. His extensive career includes roles in public health nutrition, nutrient risk assessment, and food safety, contributing to scientific advisory committees worldwide. Following retirement, Dr. Aggett continued as an External Expert for EFSA, reviewing Dietary Reference Values for essential micronutrients.

Dr. Nataliya Karyakina brings extensive expertise in toxicology and risk assessment to RSI. With a Ph.D. in Toxicology and experience at the McLaughlin Centre for Population Health Risk Assessment, she specializes in evaluating health risks from exposure to various toxic agents. Her research spans essential and toxic metals, pharmaceuticals, and nanomaterials. She has contributed to projects on chemical classification and labeling, as well as health-based regulatory guidance. Currently, she focuses on the health effects of engineered nanoalumina and diagnostic criteria for occupational manganism.

With a B.Math, M.Sc, and Ph.D in Statistics from Carleton University, Shintaro Hagiwara specialized in optimal design for quantitative high-throughput screening and a value-of-information framework for regulatory decision-making. He honed his communication skills through teaching and consulting roles at Carleton. Since joining Risk Sciences International in 2023, his focus has been on applying the VOI framework and developing health-based guideline values for chemicals.

Dr. Khan is a medical doctor with a master's in public health and a Ph.D. in population health. He currently holds a CIHR-CMHC joint fellowship applying deep learning and geospatial intelligence to predict and map cancer risk from radon gas exposure, collaborating with the University of Calgary's School of Architecture and School of Medicine. Dr. Khan also consults for the WHO on emergency health security and works as a research associate focusing on developing a next-generation risk assessment framework using new approach methodologies. His experience includes various roles in healthcare, academia, and international organizations, including the World Health Organization. Dr. Khan's expertise covers global public health, digital surveillance, population health risk assessment, advanced data analytics, and more. He has received multiple awards and published numerous peer-reviewed research articles in high-ranking journals.